水滴公司 (WDH.US) 2026年第一季度业绩电话会
文章语言:
简
繁
EN
Share
Minutes
原文
会议摘要
Waterproofs, under CEO Fish Income, reported 17th consecutive quarter of growth with 1.24 billion yuan in revenue. Insurance and healthcare businesses thrived, aided by AI advancements and user acquisition. The company secured 75 patents, including 9 international, and completed its fifth cash dividend. Future plans include 40% top-line growth by 2026, sustained by increased marketing investments and share repurchases.
会议速览
Waterproofs reported a Q1 revenue of 1.24 billion yuan, marking 17 consecutive quarters of growth. The insurance business saw a 74.1% year-over-year increase in related income, supported by stable user acquisition and improved technology. The company filed 75 patents, granted two more, and enhanced its digital healthcare solutions. Waterproofs also distributed $10.8 million in dividends and repurchased shares worth $120 million, committing to shareholder and societal returns. For 2023, Waterproofs targets 40% top-line growth, aiming to expand its user base and leverage investments for future profitability.
In Q1, insurance income surged by 74.1% year-over-year, reaching 150 million yuan, driven by continued user acquisition strategies and AI advancements. The company expanded into high-quality traffic channels, refined operations, and optimized models, contributing to a 20.24% growth in pre-existing products and an 89 million yuan contribution from new disability insurance. AI tools, including a dedicated customer complaint hotline and integrated payment channels, improved customer experience and operational efficiency, handling over 1 million service interactions monthly. The AI user service agent delivered efficiency gains of over twice the manual-only basis, with AI applications contributing approximately 87 million yuan in incremental premium.
In Q1 2026, Windsor Medical focused on AI enhancements and healthcare expansion. Key achievements include AI upgrades for linguistically diverse regions, partnerships with 243 pharmaceutical companies, a 16% year-over-year increase in patient enrollment, and securing a national invention patent for patient matching technology. The company continues to strengthen its medical case library and protocol generation capabilities, supporting sustainable growth.
The company reported a 64.8% year-over-year revenue growth to 1.24 billion in Q1, driven by insurance-related income. Operating costs increased to 1.6 billion, mainly due to business expansion and referral service costs. Despite a 9.1% year-over-year drop in net profit to 98.4 million, the firm maintained a robust cash position of 2.88 billion, reflecting strong core business growth and continued investment in traffic and AI for long-term competitiveness.
要点回答
Q:What technology advancements were highlighted, and how will they be applied in the insurance and broader industry?
A:The company has filed 75 L and related patent applications, including 9 international ones, and has been granted two more national invention patents in intelligence, semantic, and multimodal recognition. These technologies will progressively be applied to insurance, AI, intelligent customer service, and claims, enhancing service quality and efficiency.
Q:What is the focus of the company's user targeting strategy, and what is the expectation for the next year?
A:The focus of the company's user targeting strategy is on increasing marketing investment. For 2026, the company is targeting approximately 40% top-line growth with globally stable operating profit scale, expecting greater profit potential and support for the company's long-term development through user base extension.
Q:What are the new initiatives in insurance that were mentioned, and how do they aim to improve the user experience?
A:New initiatives include an upgraded inclusive cancer insurance, a new disability insurance product, and various improvements in customer experience such as a dedicated complaint hotline and integrated payment and customer service channels. These measures aim to enhance user recognition and service capabilities.
Q:How has the healthcare business performed in terms of patient enrollment and service quality?
A:The healthcare business has seen a rise in patient enrollment, with a 16% year-over-year increase in the new program A and the platform having cumulatively enrolled over 15005 hundred patients. Additionally, the intelligence for patient matching technology has secured a national invention patent, and the platform has established a standardized pipeline from data structures to intelligent patient interaction, supporting sustainable medium to long-term growth.
Q:What are the key financial performance figures for the first quarter, and how do they compare to the prior year?
A:For the first quarter, the company achieved total revenue of 1.24 billion, up 64.8% year over year. Operating costs were approximately 1.6 billion, with operating profit at around 79.5 million. Net profit attributable to all shareholders was approximately 98.4 million, down 9.1% year over year. The company's cash and cash equivalents, as well as investments and other cash positions, totaled about 2.88 billion.

Waterdrop, Inc.
Follow





